ARCHIVES

Study: BRCA2-Negative Women Could Still Have High Risk

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Consensus Conference Agenda, Registration Online.

September 1, 2000

Alan Rabson Named NCI Deputy Director

August 11, 1995

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says.

October 29, 2004